Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1438.75
-2.95 (-0.20%)
< Home < Back

Cipla’s arm unveils Nicotex Nicotine patches

Date: 22-08-2017

Cipla’s subsidiary -- Cipla Health -- has launched Nicotex Nicotine patches to help smoker kick the habit in 12 weeks. Nicotex Nicotine patch is a skin/transdermal patch that works on the proven principle of nicotine replacement therapy and helps in quit smoking in 12 weeks. The company already sells a gum with similar name.

Over 9 lakh die every year due to tobacco-related diseases in the country. One of the key challenges in this regard is the difficulty associated with quitting smoking. The patch uses a step-down dosing therapy approach that will help smokers to keep their cravings and withdrawal symptoms in check.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries.